Roche Diagnostics Corporation Signs Memorandum of Understanding for a Strategic Partnership with CapitalBio Corporation

BEIJING--(BUSINESS WIRE)--Roche Diagnostics (SWX:RO)(SWX:ROG)(Pink Sheets: RHHBY) and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.